Starpharma Holdings Limited (ASX:SPL)
Australia · Delayed Price · Currency is AUD 0.4850
+0.0050 (1.04%)
Oct 22, 2026, 10:26 AM AEDT
Starpharma Holdings Market Cap
Starpharma Holdings has a market cap or net worth of 232.67 million as of October 21, 2026. It is the 21,918th most valuable company in the world and the 436th biggest in Australia. Its market cap has increased by 91.84% in one year.
Market Cap
232.67M
Enterprise Value
222.37M
Revenue
12.67M
Global Rank
Country Rank
#436 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since September 28, 2000, Starpharma Holdings's market cap has increased from 50.00M to 232.67M, an increase of 365.35%. That is a compound annual growth rate of 6.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 230.27M | 52.94% |
| Dec 31, 2025 | 150.56M | 227.36% |
| Dec 31, 2024 | 45.99M | -34.30% |
| Dec 29, 2023 | 70.01M | -68.87% |
| Dec 30, 2022 | 224.87M | -58.74% |
| Dec 31, 2021 | 544.95M | -14.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clinuvel Pharmaceuticals | 379.97M |
| Racura Oncology | 310.77M |
| Tetratherix | 280.15M |
| BLS Pharmaceuticals | 219.94M |
| Actinogen Medical | 173.15M |
| Orthocell | 168.88M |
| Paradigm Biopharmaceuticals | 146.80M |
| Dimerix | 123.08M |